Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Isodiol International Inc ISOLF

Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Bullboard Posts
Post by jb24on Apr 10, 2018 10:27pm
273 Views
Post# 27863812

Captor Capital?

Captor Capital?

TORONTO, April 10, 2018 (GLOBE NEWSWIRE) -- Captor Capital (“CPTR” or the “Company”) (CSE:CPTR) (FRANKFURT:NMV) (OTC:NWURF) announced today that it has decided to change its business focus from a diversified investment and merchant banking company and focus solely on cannabis. This change in the focus and direction of Captor’s business is considered a Fundamental Change under Canadian Securities Exchange (“CSE”) Policy 8. In accordance with the policies of the CSE, the shareholders of Captor will have to approve this Fundamental Change before it becomes effective. 

John Zorbas, President of Captor, stated, “We have made strong investments in the cannabis industry and we are continuing to see great opportunities in cannabis for Captor to exploit in order to deliver value to our shareholders. It just makes sense for us and our shareholders that Captor focuses exclusively on cannabis.”

Trading in Captor has been halted and will remain halted at least until the meeting materials to be sent to shareholders for approval of the Fundamental Change have been reviewed and accepted by the CSE and posted to the CSE website. The halt is considered a Regulatory Halt as defined in National Instrument 23-101-Trading Rules.

For further information, please contact

John Zorbas, President
Captor Capital Corp.
416.504.3978
Johnz@captorcapital.com

Bullboard Posts